Joey Boiser, MD

Medical Director, Medical Safety Evaluation
AbbVie

Poster(s):

• (86) Efficacy and safety of flexible-dose tavapadon, an orally administered, once-daily, selective D1/D5 dopamine agonist for the treatment of early Parkinson’s disease
  Wednesday, October 29, 2025